Coenzyme Q10, antioxidant status and ApoE isoforms

BioFactors

Volumn 18, Issue 1-4, 2003, Pages 299-305

  Battino, M ^a   Giunta, S ^b   Galeazzi, L ^b   Galeazzi, R ^b   Mosca, F ^a   Santolini, C ^a   Principi, F ^a   Ferretti, G ^a   Bacchetti, T ^a   Bencivenga, R ^c   Piani, M ^c   Riganello, G ^c   Littarru, G P ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Cholesteryl esters hydroperoxide; HDL; LDL; Paraoxonase; Vitamin e

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CHOLESTEROL ESTERASE; CHOLESTERYL ESTER HYDROPEROXIDE; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; UBIDECARENONE; UNCLASSIFIED DRUG; ANTIOXIDANT; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL ESTER; DRUG DERIVATIVE; HYDROGEN PEROXIDE; UBIQUINONE;

ALLELE; ANTIOXIDANT ACTIVITY; APOLIPOPROTEIN E GENE; APOLIPOPROTEIN E2 GENE; APOLIPOPROTEIN E3 GENE; APOLIPOPROTEIN E4 GENE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ARTICLE; BLOOD; BLOOD DONOR; GENETICS;

CHANDIPURA VIRUS;

ALLELES; ANTIOXIDANTS; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; BLOOD DONORS; CHOLESTEROL ESTERS; GENOTYPE; HUMANS; HYDROGEN PEROXIDE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; UBIQUINONE; VITAMIN E;

EID: 0348049894     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520180234     Document Type: Conference Paper

References (22)

1. W.S. Simonet, N. Bucay, R.E. Pitas, S.J. Lauer and J.M. Taylor, A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C1 genes in transgeneic mice, Journal of Biological Chemistry 268 (1993), 8221-8229.
2. K.H. Weisgraber and R.W. Mahley, Human apolipoprotein E: the alzheimer's disease connection, FASEB Journal 10 (1996), 1485-1494.
3. B.W. Segelke, M. Forstner, M. Knapp, S.D. Trakhanov, S. Parkin, Y.M. Newhouse, H.D. bellamy, K.H. Weisgraber and B. Rupp, Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding, Protein Sci 9 (2000), 886-897.
4. L.-M. Dong and K.H. Weisgraber, Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins, Journal of Biological Chemistry 271 (1996), 19053-19057.
5. B. Lu, J.A. Morrow and K.H. Weisgraber, Conformational reorganization of the four helix bundle of human apolipoprotein E in binding to phospholipid, Journal of Biological Chemistry 275 (2000), 20775-20781.
6. M.J. Alberts, C. Graffagnino, C. McClenny, D. DeLong, W. Strittmatter, A.M. Saunders and A.D. Roses, ApoE genotype and survival from intracerebral hemorrhage, Lancet 346 (1995), 575.
7. B.A. Kakulas, S.D. Wilton, V.A. Fabian and T.M. Jones, Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease, Lancet 348 (1996), 483.
8. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, S. Minoshima, S.N. Thibodeau and D. Osborne, Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, New England Journal of Medicine 334 (1996), 752-758.
9. A.D. Roses, Apolipoprotein E alleles as risk factors in Alzheimer's disease, Annual Reviews in Medicine 47 (1996), 387-400.
10. A.D. Roses, A model for susceptibility polymorphisms for complex diseases: Apolipoprotein E and Alzheimer's disease, Neurogenetics 1 (1997), 3-11.
11. A.M. Saunders, O. Hulette, K.A. Welsh-Bohmer, D.E. Schmechel, B. Crain, J.R. Burke, M.J. Alberts, W.J. Strittmatter, J.C. Breitner and C. Rosenberg, Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer's disease, Lancet 348 (1996), 90-93.
12. M.A. Smith, G. Perry, P.L. Richey, M.L. Sayre, V.E. Anderson, M.F. Beal and N. Kowall, Oxidative damage in Alzheimer's, Nature 382 (1996), 120-121.
13. C. Rice-Evans and K.R. Bruckdorfer, Free radicals, lipoproteins and cardiovascular dysfunction, Molecular Aspects of Medicine 13 (1992), 1-111.
14. 10 and vitamin E on the peroxidation of human low density lipoprotein subfractions, Proceedings of the National Academy of Sciences of USA 92 (1995), 9388-9391.
15. B.H. Chung, J.P. Segres, M.J. Ray, J.D. Brunzell, J.E. Hokanson, R.M. Krauss, K. Beaudrie and J.T. Cone, Single vertical spin density gradient ultracentrifugation, Methods in Enzymology 128 (1986), 181-209.
16. O.K. Lowry, N.J. Rosebrough, A.L. Farr and P.J. Randall, Protein measurement with the Folin phenol reagent, Journal of Biological Chemistry 193 (1951), 265-275.
17. R. Higuchi, Simple and rapid preparation of samples for PCR, in: PCR Technology. Principles and Applications for DNA Amplifivation, H.A. Erlich, ed., Stockton Press, USA, 1989.
18. J.E. Hixson and D.T. Vernier. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, Journal of Lipid Research 31 (1990), 545-548.
19. C.-J. Hu, S.-M. Sung, H.-C. Liu and J.-G. Chang, Association of Apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese, Journal of the Neurological Sciences 157 (1995), 158-161.
20. F. Mosca, D. Fattorini, S. Bompadre and G.P. Littarru, Assay of coenzyme Q(10) in plasma by a single dilution step, Anal Biochem. 305 (2002), 49-54.
21. Y. Yamamoto, Chemiluminescence-based high-performance liquid chromatography assay of lipid hydroperoxides, Methods Enzymol. 233 (1994), 319-324.
22. M. Navab, S. Hama-Levy, B.J. Van Lenten, G.C. Fonarow, C.J. Cardinez, L.W. Castellani, M.L. Brennan, A.J. Lusis, A.M. Fogelman and B.N. La Du, Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio, Clin. Invest. 99 (1997), 2005-2019.